Table of Contents

company-logo

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.

CollPlant Biotechnologies Dividend Announcement

• CollPlant Biotechnologies does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on CollPlant Biotechnologies dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

CollPlant Biotechnologies Dividend History

CollPlant Biotechnologies Dividend Yield

CollPlant Biotechnologies current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing CollPlant Biotechnologies stock? Use our calculator to estimate your expected dividend yield:

CollPlant Biotechnologies Financial Ratios

P/E ratio-2.79
PEG ratio0.13
P/B ratio2.35
ROE-65.98%
Payout ratio0.00%
Current ratio6.27
Quick ratio6.14
Cash Ratio5.84

CollPlant Biotechnologies Dividend FAQ

Does CollPlant Biotechnologies stock pay dividends?
CollPlant Biotechnologies does not currently pay dividends to its shareholders.
Has CollPlant Biotechnologies ever paid a dividend?
No, CollPlant Biotechnologies has no a history of paying dividends to its shareholders. CollPlant Biotechnologies is not known for its dividend payments.
Why doesn't CollPlant Biotechnologies pay dividends?
There are several potential reasons why CollPlant Biotechnologies would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will CollPlant Biotechnologies ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While CollPlant Biotechnologies has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is CollPlant Biotechnologies a dividend aristocrat?
CollPlant Biotechnologies is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is CollPlant Biotechnologies a dividend king?
CollPlant Biotechnologies is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is CollPlant Biotechnologies a dividend stock?
No, CollPlant Biotechnologies is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy CollPlant Biotechnologies stocks?
To buy CollPlant Biotechnologies you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy CollPlant Biotechnologies stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.